Summary
Introduction
Hereditary cerebral haemorrhage with amyloidosis-Dutch type (HCHWA-D) is a rare autosomal dominant disorder afflicting members of four large families, originating from two small adjacent coastal villages in the Netherlands. The pedigrees were traced back to the end of the 17th century, but no ancestral connections could be found between the families. Some HCHWA-D patients have been described in the United States of America, but these patients also originate from The Netherlands (Fernandez-Madrid et al., 1991) . In HCHWA-D patients, cerebral amyloid angiopathy is the predominant histopathological hallmark. In addition, parenchymal deposits that resemble diffuse and neuritic plaques are also present (Maat-Schieman et al., 1996) . The amyloid deposits are composed of the amyloid β (Aβ) protein, which is also the major constituent of parenchymal and vascular deposits in Alzheimer's disease, Down's syndrome and of the vascular deposits in sporadic cerebral amyloid angiopathy.
HCHWA-D is caused by a single base mutation at codon 693 of the amyloid β precursor protein (βPP) gene located on chromosome 21 (Levy et al., 1990; Van Broeckhoven et al., 1990) , resulting in recurrent haemorrhagic strokes and dementia (Bornebroek et al., 1996a) . The first stroke usually occurs between the ages of 40 and 65 years (mean 50.2 years) and two-thirds of the patients die as a consequence of it (Luyendijk et al., 1988; Wattendorf et al., 1995) . Onethird of the patients die within a year of the first stroke and half of them within 2 weeks (Wattendorf et al., 1995) . Those who survive, suffer recurrent strokes that lead to severe disablement. The longest reported survival is 22 years. Dementia can develop after the first stroke, but sometimes it is the first or only symptom of HCHWA-D (Wattendorf et al., 1982; Haan et al., 1992; Bornebroek et al., 1996b) . The progression of dementia can be in a stepwise fashion related to the strokes, as in vascular dementia, but it can also progress in a chronic way between strokes, suggesting a more chronic type of brain damage (Haan et al., , 1992 .
Though HCHWA-D is caused by a dominant mutation, the phenotypic expression is very variable suggesting modulation by additional factors. The apolipoprotein E (APOE) ε4 allele, a well-known genetic risk factor for Alzheimer's disease and sporadic cerebral amyloid angiopathy, does not influence the clinical expression or the structural brain lesions in HCHWA-D (Haan et al., 1994; Bornebroek et al., 1997a) . Likewise, a recently described intronic polymorphism in the presenilin-1 gene, an autosomal dominant gene for familial early onset Alzheimer's disease, does not modulate the clinical expression of HCHWA-D (Bornebroek et al., 1997b) . Hence, there must be other factors that affect the phenotypic expression of the βPP693 mutation. In Alzheimer's disease, female sex, maternal transmission and year of birth have been suggested as risk factors modulating the clinical expression of the disease (Beard et al., 1994; Edland et al., 1996; Heyman et al., 1996) . Therefore, we investigated the influence of these risk factors on mortality in individuals suffering from HCHWA-D.
Patients and methods
Since the early sixties clinical and genealogical data have been collected from families with HCHWA-D. Extensive genealogical searches were performed using official records of birth, marriage and death to identify common ancestors and to trace all family members at risk. Family members and general practitioners were interviewed to investigate whether individuals had suffered a stroke or not. Case ascertainment was performed in four ways: (i) confirmation of the codon 693 mutation in the βPP gene (DNA analysis has been used to confirm the diagnosis and also to detect presymptomatic mutation carriers; Bakker et al., 1991) ; (ii) histological examination of autopsy or biopsy material demonstrating cerebral amyloid angiopathy; (iii) medical records reporting a haemorrhagic stroke, often extended with radiological investigations (CT/MRI); (iv) if medical records were not available, the diagnosis was based on heteroanamnesis of (recurrent) stroke(s). All cases had at least one offspring in which diagnosis HCHWA-D was confirmed, based on DNA analysis, histopathological or clinical examination.
Within pedigrees, all first degree relatives of the HCHWA-D patients have an a priori Mendelian risk of 50% of being affected. The patient together with all his brothers and sisters form a complete sibship. Sibships without patients were not studied.
Statistical analyses
The mortality of HCHWA-D was compared with the Dutch population standardized for age, sex and year of birth (standardized mortality ratio), i.e. relative mortality rate, and 95% confidence intervals (CIs) were calculated assuming a Poisson distribution of the number of deaths. The majority of the patients included were selected on the basis of symptoms; only a few cases were based on positive presymptomatic DNA testing. Since onset of symptoms of HCHWA-D is after the age of 40 years, only patients 40 years or older were included in this study. We omitted events in the first 40 years of those who were included, to avoid underestimation of the mortality rate due to inclusion of individuals with low prior mortality risk. Also some mutation carriers may have escaped identification as patients because of premature death.
Cumulative survival was investigated using Kaplan-Meier estimates. Influences of sex, parental transmission and year of birth on mortality were studied using a Cox's proportional hazard model. Statistical significance was assessed at the 5% level of probability.
Results
HCHWA-D has been described in four large families and two smaller families that have not yet been linked to any of the four large families. The two smaller families also originate from Katwijk and segregate the βPP693 mutation. In three of the large families eight generations were traced back, the other large family being traced back for four generations. Genealogical searches went back to the 17th century but did not provide information on whether the ancestors suffered a stroke or not and therefore the oldest generations of the pedigrees were not included in this study. By December 1, 1995, a total of 420 family members aged Ͼ40 years were identified, with an a priori 50% risk of being affected. The 420 individuals are part of 87 complete sibships; each sibship had at least one HCHWA-D patient.
From a total of 187 affected individuals, the diagnosis was based on confirmation of the βPP693 mutation in 60 individuals, on histopathological examination in 37 patients, on data obtained from medical records in 55 patients and on heteroanamnesis in 35 patients. The latter patients had offspring with a diagnosis of HCHWA-D based on medical records, histopathological examination or DNA analysis of the βPP693 mutation. In 20 relatives, DNA analysis excluded the βPP693 mutation eliminating their risk for HCHWA-D. Only a few family members requested presymptomatic DNA testing and for ethical reasons we did not approach at risk family members actively (Hersch et al., 1994) . The total group of patients consisted of 96 men and 91 women. In 87 patients, the disease was inherited from the father, in 89 cases from the mother and in 11 cases parental transmission was unknown. Concerning the 11 cases with an unknown line of transmission, there were three patients whose father and mother were both affected, but DNA analysis did not reveal homozygosity for the βPP 693 mutation, and in the other eight patients the affected parent was not known. Of the 187 patients studied, 145 patients had died while the remaining 42 were alive during the whole study. Mean age at death (Ϯ SD) was 59.6 Ϯ 10.2 years (range 41.4-86.7 years). Survival of the patients was not significantly different between the four families (P ϭ 0.3), therefore all (Table 2) . When compared with the Dutch population the mortality in the HCHWA-D patients was increased fourfold (relative mortality rate 4.0; 95% CI 3.4-4.7), in males the relative mortality rate was 2.6 (95% CI 2.1-3.3) and in females 8.0 (95% CI 6.2-9.9).
Within the HCHWA-D families, the mortality rate was significantly higher for females ( Fig. 1; relative to males 1.7, 95% CI 1.2-2.5, P ϭ 0.002) but lower for maternal transmission ( Fig. 2; relative to paternal 0.7, 95% CI 0.5- 1.0, P ϭ 0.04) while the year of birth did not significantly change the mortality rate (Table 3) .
We repeated analyses in a subgroup of patients born before 1925 to exclude ascertainment bias due to exclusion of asymptomatic patients born between 1925 and 1950. The mortality rates were similar to those in the total patient group (Table 3) . The mortality ratio (females : males) was again 1.7 (95% CI 1.1-2.5) and that for maternal : paternal transmission was again 0.7 (95% CI 0.4-1.0).
Discussion
This study of a large group of HCHWA-D patients belonging to four large families and two small families, provides interesting new findings concerning the clinical expression of HCHWA-D. Cumulative survival did not differ between the four large HCHWA-D families supporting the notion that these families might have a common founder, and justifying the pooling of all patients' data. The mortality rate of HCHWA-D patients was fourfold increased compared with that of the Dutch population. When compared with the Dutch population mortality rate in female patients was eightfold higher, and in male patients twofold higher. Remarkably, in HCHWA-D families, the mortality rate in female patients was nearly twofold higher than in male patients, whereas in the Dutch population, males have higher mortality rates than females. Also mortality rate was significantly increased when the disease was paternally transmitted, independently of the sex of the offspring. No correlation was found between mortality rate and year of birth.
It is possible that the mortality rate of HCHWA-D patients compared with the Dutch population is overestimated as predominantly severe cases came to clinical attention. Indeed from the total group of individuals at risk, less than half of them had been identified as patients. In a few sibships, we could not exclude completely that selection of severe cases had taken place (generation IV in family AM1 and generation V in family AM2). However, after excluding these sibships from the analyses, the mortality rates did not change (data not presented). Moreover, equal numbers of females and males and maternal and paternal transmission were found in this study and therefore mortality rates are unlikely to be biased because of preferential ascertainment of female cases or paternally transmitted cases.
There are several possible explanations for the lack of decrease of mortality from HCHWA-D over the years. In this century, general health has improved and life expectancy increased, mainly because of improved survival in the first years after birth. However, this period was excluded from our analyses; it was unlikely that it would influence mortality from HCHWA-D which affects middle-aged individuals. Primary prevention, by control of hypertension and reduction of other vascular risk factors, may have contributed to a decline in mortality, as described for stroke patients (McGovern et al., 1993; Shahar et al., 1995) . However, in a retrospective study influence of these risk factors cannot be reliably studied. Nevertheless, there is no indication that these factors influenced the mortality from HCHWA-D since the mortality rate was not correlated with year of birth.
There is no simple explanation for the finding that death occurred at a significantly younger age in female HCHWA-D patients. In the Dutch population women live longer than men, and similar trends are found in studies of Alzheimer's disease and stroke patients (McGovern et al., 1992; Higgins and Thom, 1993; Heyman et al., 1996) . In HCHWA-D, age at first stroke does not differ between female and male patients (data not presented). Therefore, sex is not a risk factor influencing the onset of strokes, but it does determine the clinical progression of the disease. One of the main differences between men and women is the production of oestrogen. In vitro studies showed that oestrogen stimulates the α-secretase metabolism of βPP (Jaffe et al., 1994) . However, influences on the survival from strokes or dementia have not been described. In sporadic cerebral amyloid angiopathy no influence of sex on the clinical course has been described. Also, in hereditary cystatin C amyloid angiopathy, which is clinically related to HCHWA-D despite an earlier age at onset, an influence of sex on the clinical course has not been described (Jensson et al., 1987) . A wellknown genetic risk factor for Alzheimer's disease is the APOE genotype, which has sometimes been described to influence the survival from Alzheimer's disease (Heyman et al., 1996) . Moreover, oestrogen may interact with apoE and indirectely influence survival (Honjo et al., 1995) . However, in HCHWA-D the APOE genotype does not affect the mortality from strokes or any other clinical parameter (Haan et al., 1994; Bornebroek et al., 1997a) . Nevertheless effect of APOE genotype on the correlation between sex and mortality rate was studied but not found to be present (data not shown). Another remarkable finding is that HCHWA-D patients with an affected father live for a shorter time than those with an affected mother; however, these results are of borderline significance. It is known that autosomal dominant genes are inherited in equal proportions from father and mother and that differences in phenotypic expression may be influenced by the sex of the transmitting parent. For example, in Huntington's disease, the mean age at onset is lower for paternal compared with maternal transmission (Roos et al., 1991) , whereas in myotonic dystrophia, the severe congenital form of the disease occurs more frequently among the offspring of affected mothers (Mulley et al., 1993) . A study of families with Alzheimer's disease reported an increased number of affected mothers in proband with the disease. However, they did not mention an effect on survival. In familial Alzheimer's disease due to known mutations, no parental sex effect on survival has been described. Some possible mechanisms for parental sex effects have been suggested (Chatkupt et al., 1995) , but there is no explanation for the parental sex effects found in this study, where the patients had a G to C mutation in the βPP 693 codon. This clinical study possibly gives the first indication that parental sex effects could appear in diseases caused by a single base mutation.
